TherapeuticsMD (TXMD) Short Report 'Sound Like a Rehash', Buy on Weakness - Guggenheim

November 29, 2016 12:35 PM EST Send to a Friend
Guggenheim analyst Louise Chen is telling clients to buy TherapeuticsMD (NYSE: TXMD) on today's weakness triggered by a short presentation ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login